Molecular mechanisms involved in the therapeutic action of the stimulation of soluble guanylate cyclase (sGC) in an experimental model of guinea pig exposed to cigarette smoke

V. Peinado (Barcelona, Spain), D. Aguilar (Barcelona, Spain), T. Paul (Barcelona, Spain), I. Blanco (Barcelona, Spain), O. Tura-Ceide (Barcelona, Spain), J. Barberà (Barcelona, Spain)

Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Session: Involvement of the environment and inflammation in pulmonary remodelling
Session type: Thematic Poster
Number: 2435
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Peinado (Barcelona, Spain), D. Aguilar (Barcelona, Spain), T. Paul (Barcelona, Spain), I. Blanco (Barcelona, Spain), O. Tura-Ceide (Barcelona, Spain), J. Barberà (Barcelona, Spain). Molecular mechanisms involved in the therapeutic action of the stimulation of soluble guanylate cyclase (sGC) in an experimental model of guinea pig exposed to cigarette smoke. 2435

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of soluble guanylate cyclase (sGC) stimulation in guinea pigs chronically exposed to cigarette smoke
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012

Soluble guanylate cyclase stimulators revert in vitro cigarette smoke effects through JNK pathway normalization
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Cigarette smoke extract (CSE) promotes acetylcholine (ACh) mediated inflammation and oxidative stress by PEBP1/Raf-mediated MEK and ERK pathway in human bronchial epithelial cells
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015

Modulatory effect of muscarinic receptors on IL-8 release induced by cigarette smoke extract and acrolein in normal human airway smooth muscle cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010


Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils
Source: Eur Respir J 2001; 18: Suppl. 33, 161s
Year: 2001

Muscarinic receptor stimulation potentiates cigarette smoke extract induced IL-8 production by airway smooth muscle
Source: Annual Congress 2008 - Cell biology of asthma and COPD
Year: 2008

Down-regulation of soluble guanylyl cyclase in asthma contributes to airway hyperreactivity
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005

Soluble guanylyl cyclase expression is reduced in acute lung injury
Source: Eur Respir J 2006; 28: Suppl. 50, 398s
Year: 2006

Potent anti-inflammatory effects of the highly selective iNOS inhibitor Byk402750 in a mouse model of cigarette smoke induced inflammation
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008

17-beclomethasone monopropionate or inhibition of MAPK p38 signalling abolish IL-8 release stimulated by cigarette smoke extract or acrolein in normal human airway smooth muscle cells
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010


The stimulator of soluble guanylate cyclase riociguat protects against bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011

Effect of phosphodiesterase 4 (PDE-4) inhibitor – rolipram with or without co-administration of dexamethasone on experimental asthma - guinea pig model
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004

Nonsteroidal anti-inflammatory drugs upregulate function of wild-type and mutant CFTR
Source: Eur Respir J 2008; 32: 334-343
Year: 2008



Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern
Source: Eur Respir J 2009; 33: 717-721
Year: 2009


Cigarette smoke exposure disrupts VEGF signalling through the kinase insert-domain receptor (KDR) in rat lungs
Source: Eur Respir J 2004; 24: Suppl. 48, 30s
Year: 2004

A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

The role of guanylyl cyclase in resistive breathing
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013



Inhibition of β-adrenoceptors alleviated mucus secretion and emphysema in cigarette smoke exposed rat model
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011

H2S excites guinea pig bronchus via TRPV1 activation
Source: Eur Respir J 2004; 24: Suppl. 48, 219s
Year: 2004

Effects of a soluble guanylate cyclase stimulator, BAY 41-8543, upon right ventricular function in experimental pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012